Delivery Order SPE2DB25D3020-SPE2DB25FWKLN
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Sunosi 150 mg tablets (30-count units) valued at $21,491.34 under a firm fixed-price contract. This competitively awarded, non-set-aside delivery order is expected to be completed by September 22, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,141.29 to AmerisourceBergen Drug Corp on July 8, 2025, for the supply of Sunosi 150 mg tablets in a quantity of 30 units. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procurement procedures. The contract is scheduled for ultimate completion on July 9, 2025, with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $1,154.87 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Sunosi 150 mg tablets (30-count units). This competitive, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by August 13, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a $2,445.76 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Sunosi 150 mg tablets (30-count). This firm fixed-price contract represents a non-set-aside competitive award and is scheduled for completion by September 5, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a $4,025.37 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Sunosi 150 mg tablets (30-count package). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 5, 2025, and performance executed from the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 18, 2025, for the supply of Sunosi 75 mg tablets (30-count packages) valued at $1,344.45. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The contract is scheduled for ultimate completion on September 19, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Sunosi 150 mg tablets (30-count units) at a firm fixed price totaling $1,345.47. This non-set-aside contract is a child order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which carries a ceiling value of $999,999,999.00 and extends through December 2026. The delivery order is...
- The Defense Logistics Agency awarded a $2,721.90 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Sunosi 75 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 19, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,322.37 to AmerisourceBergen Drug Corp for SUNOSI 150 mg tablets (30-count supply) on August 18, 2025, with completion scheduled for August 19, 2025. This firm fixed price contract, placed through a non-set-aside competitive procurement, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the contractor's location in...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for 30 tablets of Sunosi 150 mg, a medication used to treat excessive daytime sleepiness. This competitive, firm fixed-price delivery order was awarded on September 15, 2025, with a ceiling value of $1,345.47 and an ultimate completion date of September 16, 2025. The contract carries no set-aside designation and represents a small-value transaction under the company's larger federal pharmaceutical...
- SPE2DB25D3020Indefinite Delivery Contract
- SPE2DB25D3020-SPE2DB25FWKLNDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Sunosi 150 mg tablets (30-count packaging) valued at $1,013.56. This firm fixed-price delivery order, which is not set-aside, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion master agreement running through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement needs across military and veteran healthcare systems. This delivery order falls within AmerisourceBergen's comprehensive pharmaceutical supply portfolio under the DLA Troop Support Medical contract vehicle, which enables the company to provide brand-name and generic medications, vaccines, and specialized medical supplies to support military healthcare programs globally. Sunosi is a prescription wakefulness-promoting agent used in the treatment of excessive daytime sleepiness, reflecting the company's role in supplying neurological and specialty medications to Defense Health Agency and other federal healthcare systems. The contract has an ultimate completion date of September 8, 2025, and represents one of numerous competitively awarded delivery orders that demonstrate AmerisourceBergen's capability to fulfill federal medical supply requirements across varying transaction values.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 9/5/25 |